Cargando…
Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis
Alpha-glucosidase inhibitors (AGIs) was reported to be associated with several rare adverse hepatic events, but with inconsistent results. We aimed to investigate the risk of hepatotoxicity associated with the use of AGIs in patients with type 2 diabetes mellitus (T2DM), and performed a systematic r...
Autores principales: | Zhang, Longhao, Chen, Qiyan, Li, Ling, Kwong, Joey S. W., Jia, Pengli, Zhao, Pujing, Wang, Wen, Zhou, Xu, Zhang, Mingming, Sun, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011653/ https://www.ncbi.nlm.nih.gov/pubmed/27596383 http://dx.doi.org/10.1038/srep32649 |
Ejemplares similares
-
The Effects of Clinical Decision Support Systems on Medication Safety: An Overview
por: Jia, Pengli, et al.
Publicado: (2016) -
An Evaluation of the Effects of Human Factors and Ergonomics on Health Care and Patient Safety Practices: A Systematic Review
por: Mao, Xuanyue, et al.
Publicado: (2015) -
Cinnamoyl Sucrose Esters as Alpha Glucosidase Inhibitors for the Treatment of Diabetes
por: Devaraj, Surabhi, et al.
Publicado: (2021) -
Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes
por: van de Laar, Floris Alexander
Publicado: (2008) -
Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes
por: Coleman, Ruth L., et al.
Publicado: (2019)